Open
Do sulfonylureas & glinides improve costs & health-care use more than other treatments?
Not modeled yetTrial evidence exists, but no mechanistic model yetWithout a model there is no decisive experiment to propose. Help build it. →
Where the evidence stands
No claim has formed for this comparison yet. The trials below are registered, but none decides it.
Already under way
No registered trial that could settle this is recruiting or active.
The evidence so far
- Registered trials
- 6
- With posted results
- 1
- Published papers
- 1
Papers
- Comparison of diabetes-associated secondary healthcare utilization between alternative oral antihyperglycaemic dual therapy combinations with metformin in patients with type 2 diabetes: an observational cohort study.Observational study · 2015
Trials
- A Pilot Study of Outpatient Discharge Therapy With Saxagliptin + Metformin XR or Sulphonylurea for Recently Diagnosed Type 2 Diabetes Presenting With Severe HyperglycemiaNCT01267448
- Clinical and Economic Impact of 2nd Line Initiation of Empagliflozin After Metformin, as Compared to 2nd Line Initiation of Sulfonylurea After Metformin in Patients With Type 2 Diabetes and Cardiovascular DiseaseNCT05102071
- Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney DiseaseNCT03921242
- Prediction of the SEPRA Diabetes Trial in Healthcare Claims DataNCT05577728
- STEP-DC: Stop Emergency Room Visits for Uncontrolled Hyperglycemia Project in the District of ColumbiaNCT01033773 · 1 posted result
- Transforming Hypertension Treatment in Nigeria Using a Type II Hybrid, Interrupted Time Series Design - Aim 3NCT07589387